Arca
Skip to content
Tools
Tools

HTR4: 5-hydroxytryptamine receptor 4

G protein-coupled receptor for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone and a mitogen.

  • Drugs that act on it: 16
  • Approved: 4
  • In phases 1 to 3: 12
  • Sponsors: 11

Who is on it, and how far along

Every drug ChEMBL records acting on HTR4, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 16

Approved4

  • Metoclopramide
  • Prucalopride
  • Cisapride
  • Tegaserod

Phase 32

  • Mosapride
  • Renzapride

Phase 210

  • Levosulpiride
  • Capeserod
  • Clebopride
  • Felcisetrag
  • Naronapride
  • Piboserod
  • PRX-03140
  • Relenopride
  • Revexepride
  • Velusetrag

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    • Alizyme16%
    • Dr. Falk Pharma GmbH16%
    • Epix Pharmaceuticals, Inc.16%
    • IlDong Pharmaceutical Co Ltd16%

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 12 of 16 act as: Serotonin 4 (5-HT4) receptor agonist; the rest name their own mechanism.
    MetoclopramideBoxed warningApprovedANI PharmaceuticalsSmall moleculeAgonist20
    PrucaloprideApprovedTakeda Pharmaceuticals USASmall moleculeAgonist9
    CisaprideWithdrawn Boxed warningApprovedJohnson & JohnsonSmall moleculeAgonist0
    TegaserodWithdrawnApprovedAlfasigmaSmall moleculePartial agonistSerotonin 4 (5-HT4) receptor partial agonist0
    MosapridePhase 3IlDong Pharmaceutical Co LtdSmall moleculeAgonist4
    RenzapridePhase 3AlizymeSmall moleculeAgonist0
    LevosulpiridePhase 2—Small moleculeAgonist1
    CapeserodPhase 2—Small moleculePartial agonistSerotonin 4 (5-HT4) receptor partial agonist0
    ClebopridePhase 2—Small moleculeAgonist0
    FelcisetragPhase 2Takeda Pharmaceuticals USASmall moleculeAgonist0
    NaronapridePhase 2Dr. Falk Pharma GmbHSmall moleculeAgonist0
    PiboserodPhase 2GSKSmall moleculeAntagonistSerotonin 4 (5-HT4) receptor antagonist0
    PRX-03140Phase 2Epix Pharmaceuticals, Inc.Small moleculePartial agonistSerotonin 4 (5-HT4) receptor partial agonist0
    RelenopridePhase 2SKSmall moleculeAgonist0
    RevexepridePhase 2Takeda Pharmaceuticals USASmall moleculeAgonist0
    VelusetragPhase 2Theravance BiopharmaSmall moleculeAgonist0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 21 in all, from ClinicalTrials.gov.
    PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low MoodPrucaloprideNot applicableRecruitingUniversity of OxfordSep 30, 2026
    Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal AnesthesiaMetoclopramidePhase 4RecruitingSanliurfa Education and Research HospitalJul 31, 2026
    Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic CholecystectomyMetoclopramidePhase 4RecruitingFaisalabad Medical UniversityJun 10, 2026
    Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion TreatmentMetoclopramidePhase 4Not yet recruitingMontefiore Medical CenterJun 8, 2026
    Postoperative GI Dysfunction and Nutrition in Malnourished Cancer Surgery PatientsMetoclopramide—Not yet recruitingArma Ltd.Jun 3, 2026
    Clinical Study on the Treatment of Gastrointestinal Dysfunction After Knee Joint Surgery Under General Anesthesia With Floating NeedleMosaprideNot applicableEnrolling by invitationZhenyu ZhangMay 26, 2026
    Dexamethasone Plus Metoclopramide Versus Paracetamol/NSAIDs for Primary HeadacheMetoclopramidePhase 4Not yet recruitingPak Emirates Military HospitalMay 22, 2026
    Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic CholecystectomyMetoclopramidePhase 4Not yet recruitingAssiut UniversityJan 22, 2026
    IV Injection of Metoclopramide With or Without DexamethasoneMetoclopramideEarly phase 1Not yet recruitingAhmed Nassar Ibrahim MohammedJan 15, 2026
    Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and VomitingMetoclopramidePhase 3RecruitingAffiliated Hospital of Qinghai UniversityOct 6, 2025
    Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional DyspepsiaMosapridePhase 4RecruitingXijing Hospital of Digestive DiseasesSep 19, 2025
    Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in AdultsPrucaloprideEarly phase 1Not yet recruitingHospital de Clínicas Dr. Manuel QuintelaAug 17, 2025
    The Effect of Two Prokinetics in Patients With Functional DyspepsiaMosaprideNot applicableActive, not recruitingEunpyeong St. Mary's HospitalJul 31, 2025
    Evolution of the Chicago Classification: Bridging Physiology and MechanicsPrucaloprideNot applicableRecruitingNorthwestern UniversityMar 19, 2025
    A Comparative Evaluation of Mosapride Versus Metoclopramide for Enteral Feeding Intolerance in Critically Ill PatientsMosapridePhase 3Not yet recruitingAin Shams UniversityFeb 14, 2025
    Impact of Varying Doses of Prucalopride on Improving Gut Function Recovery After Elective Colorectal SurgeryPrucalopridePhase 3RecruitingFuture University in EgyptFeb 10, 2025
    Prucalopride for Cognitive Functioning in SchizophreniaPrucaloprideNot applicableNot yet recruitingUniversity of PittsburghJun 25, 2024
    Gastrointestinal Dysmotility on Aspiration RiskPrucalopridePhase 4RecruitingBoston Children's HospitalJul 13, 2022
    A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During PregnancyPrucalopride—Active, not recruitingTakedaJul 14, 2021
    Post-Marketing Study of Prucalopride Safety In PregnancyPrucalopride—Active, not recruitingTakedaMay 3, 2021
    Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular EdemaLevosulpiridePhase 2RecruitingCarmen ClappMay 22, 2017

    Diseases most associated with it

    Open Targets association score, 0 to 1; all associations
    Constipation disorder
    0.59
    Post operative nausea and vomiting
    0.56
    Gastrointestinal disease
    0.53
    Gastroesophageal reflux disease
    0.53
    Hypertensive disorder
    0.49
    Nausea
    0.47

    Genes and related targets

    Complexes and families that share a gene with this target
    Genes
    HTR4

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1875, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q13639, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.